Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism

Author： Wattanapitayakul S.K.   Mihm M.J.   Young A.P.   Bauer J.A.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.7, 2001-07, pp. : 361-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial nitric oxide synthase gene: prospects for treatment of heart disease

By Cooke Glen E   Doshi Amit   Binkley Philip F  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1723-1734

Future Medicine

Access to resources Recommend Favorite

Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction

By  

Current Pharmaceutical Design, Vol. 11, Iss. 31, 2005-12 ,pp. : 4059-4067

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issues: Therapeutic Strategies to Target Endothelial Nitric-Oxide Synthase (eNOS))

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3501-3502

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial nitric oxide synthase: the Cinderella of inflammation?

By Cirino G.   Fiorucci S.   Sessa W.C.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 2, 2003-02 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors with cardiovascular therapeutic potential

By Hansen Jr. D.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite